Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This study assessed the efficacy and safety of the valsartan/amlodipine 160/5 mg single-pill
combination in patients with uncomplicated essential hypertension not adequately controlled
(MSDBP ≥90 mmHg and <110 mmHg) on valsartan 160 mg alone.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Amlodipine Amlodipine, Valsartan Drug Combination Valsartan